{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T10:07:06Z","timestamp":1771063626752,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Key Project of Wuxi Science and Technology Bureau, Jiangsu Province","award":["Y2021011"],"award-info":[{"award-number":["Y2021011"]}]},{"name":"the Special Fund for Hospital Key Disciplines of 904th Hospital of Joint Logistic Support Force of PLA","award":["XK20240201"],"award-info":[{"award-number":["XK20240201"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"DOI":"10.1007\/s11010-025-05416-7","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T17:32:22Z","timestamp":1761327142000},"page":"493-507","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Growth differentiation factor 11 attenuates doxorubicin-induced cardiotoxicity by inhibiting myocardial pyroptosis and oxidative stress"],"prefix":"10.1007","volume":"481","author":[{"given":"Jiangping","family":"Ye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yehong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongxia","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rikang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuting","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianhui","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gangjun","family":"Zong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,24]]},"reference":[{"issue":"3","key":"5416_CR1","doi-asserted-by":"publisher","DOI":"10.1161\/circheartfailure.119.005910","volume":"12","author":"A Narezkina","year":"2019","unstructured":"Narezkina A, Nasim K (2019) Anthracycline cardiotoxicity. Circ Heart Fail 12(3):e005910. https:\/\/doi.org\/10.1161\/circheartfailure.119.005910","journal-title":"Circ Heart Fail"},{"issue":"2","key":"5416_CR2","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.113.000665","volume":"3","author":"VS Hahn","year":"2014","unstructured":"Hahn VS, Lenihan DJ, Ky B (2014) Cancer therapy-induced cardiotoxicity: basic mechanisms and potential cardioprotective therapies. J Am Heart Assoc 3(2):e000665. https:\/\/doi.org\/10.1161\/jaha.113.000665","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"5416_CR3","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/s41419-021-03614-x","volume":"12","author":"E Christidi","year":"2021","unstructured":"Christidi E, Brunham LR (2021) Regulated cell death pathways in doxorubicin-induced cardiotoxicity [J]. Cell Death Dis 12(4):339. https:\/\/doi.org\/10.1038\/s41419-021-03614-x","journal-title":"Cell Death Dis"},{"key":"5416_CR4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.toxlet.2019.02.013","volume":"307","author":"M Songbo","year":"2019","unstructured":"Songbo M, Lang H, Xinyong C et al (2019) Oxidative stress injury in doxorubicin-induced cardiotoxicity. Toxicol Lett 307:41\u201348. https:\/\/doi.org\/10.1016\/j.toxlet.2019.02.013","journal-title":"Toxicol Lett"},{"issue":"4","key":"5416_CR5","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1097\/fjc.0000000000000350","volume":"67","author":"ZQ Wang","year":"2016","unstructured":"Wang ZQ, Chen MT, Zhang R et al (2016) Docosahexaenoic acid attenuates doxorubicin-induced cytotoxicity and inflammation by suppressing NF-\u03baB\/iNOS\/NO signaling pathway activation in H9C2 cardiac cells. J Cardiovasc Pharmacol 67(4):283\u2013289. https:\/\/doi.org\/10.1097\/fjc.0000000000000350","journal-title":"J Cardiovasc Pharmacol"},{"issue":"7575","key":"5416_CR6","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/nature15514","volume":"526","author":"J Shi","year":"2015","unstructured":"Shi J, Zhao Y, Wang K et al (2015) Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature 526(7575):660\u2013665. https:\/\/doi.org\/10.1038\/nature15514","journal-title":"Nature"},{"key":"5416_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2021.108053","volume":"236","author":"S Toldo","year":"2022","unstructured":"Toldo S, Mezzaroma E, Buckley LF et al (2022) Targeting the NLRP3 inflammasome in cardiovascular diseases. Pharmacol Ther 236:108053. https:\/\/doi.org\/10.1016\/j.pharmthera.2021.108053","journal-title":"Pharmacol Ther"},{"issue":"1","key":"5416_CR8","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12933-024-02258-3","volume":"23","author":"J Zhang","year":"2024","unstructured":"Zhang J, Wang G, Shi Y et al (2024) Growth differentiation factor 11 regulates high glucose-induced cardiomyocyte pyroptosis and diabetic cardiomyopathy by inhibiting inflammasome activation. Cardiovasc Diabetol 23(1):160. https:\/\/doi.org\/10.1186\/s12933-024-02258-3","journal-title":"Cardiovasc Diabetol"},{"key":"5416_CR9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.yjmcc.2019.08.009","volume":"136","author":"L Meng","year":"2019","unstructured":"Meng L, Lin H, Zhang J et al (2019) Doxorubicin induces cardiomyocyte pyroptosis via the TINCR-mediated posttranscriptional stabilization of NLR family pyrin domain containing 3. J Mol Cell Cardiol 136:15\u201326. https:\/\/doi.org\/10.1016\/j.yjmcc.2019.08.009","journal-title":"J Mol Cell Cardiol"},{"issue":"4","key":"5416_CR10","doi-asserted-by":"publisher","DOI":"10.20517\/jca.2023.23","volume":"3","author":"LB Driss","year":"2023","unstructured":"Driss LB, Lian J, Walker RG et al (2023) GDF11 and aging biology - controversies resolved and pending. J Cardiovasc Aging 3(4):10.20517\/jca.2023.23","journal-title":"J Cardiovasc Aging"},{"key":"5416_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2023.06.007","author":"Y Shao","year":"2023","unstructured":"Shao Y, Wang Y, Xu J et al (2023) Growth differentiation factor 11: a new hope for the treatment of cardiovascular diseases. Cytokine Growth Factor Rev. https:\/\/doi.org\/10.1016\/j.cytogfr.2023.06.007","journal-title":"Cytokine Growth Factor Rev"},{"issue":"3","key":"5416_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2023.119656","volume":"1871","author":"Y Shao","year":"2024","unstructured":"Shao Y, Li M, Wang Y et al (2024) GDF11 mitigates high glucose-induced cardiomyocytes apoptosis by inhibiting the ALKBH5-FOXO3-CDR1as\/Hippo signaling pathway. Biochim Biophys Acta 1871(3):119656. https:\/\/doi.org\/10.1016\/j.bbamcr.2023.119656","journal-title":"Biochim Biophys Acta"},{"key":"5416_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtemb.2024.127516","volume":"86","author":"A Mohamed","year":"2024","unstructured":"Mohamed A, Ragheb MA, Shehata MR et al (2024) In vivo cardioprotective effect of zinc oxide nanoparticles against doxorubicin-induced myocardial infarction by enhancing the antioxidant system and nitric oxide production. J Trace Elem Med Biol 86:127516. https:\/\/doi.org\/10.1016\/j.jtemb.2024.127516","journal-title":"J Trace Elem Med Biol"},{"issue":"12","key":"5416_CR14","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1136\/heartjnl-2017-312103","volume":"104","author":"PA Henriksen","year":"2018","unstructured":"Henriksen PA (2018) Anthracycline cardiotoxicity: an update on mechanisms, monitoring and prevention. Heart 104(12):971\u2013977. https:\/\/doi.org\/10.1136\/heartjnl-2017-312103","journal-title":"Heart"},{"key":"5416_CR15","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv357","author":"F Shaikh","year":"2016","unstructured":"Shaikh F, Dupuis LL, Alexander S et al (2016) Cardioprotection and second malignant neoplasms associated with dexrazoxane in children receiving anthracycline chemotherapy: a systematic review and meta-analysis. J Natl Cancer Inst. https:\/\/doi.org\/10.1093\/jnci\/djv357","journal-title":"J Natl Cancer Inst"},{"key":"5416_CR16","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.freeradbiomed.2018.08.032","volume":"129","author":"D Liu","year":"2018","unstructured":"Liu D, Ma Z, Di S et al (2018) AMPK\/PGC1\u03b1 activation by melatonin attenuates acute doxorubicin cardiotoxicity via alleviating mitochondrial oxidative damage and apoptosis. Free Radic Biol Med 129:59\u201372. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2018.08.032","journal-title":"Free Radic Biol Med"},{"key":"5416_CR17","doi-asserted-by":"publisher","DOI":"10.1177\/17590914211018100","volume":"13","author":"R Bai","year":"2021","unstructured":"Bai R, Lang Y, Shao J et al (2021) The role of NLRP3 inflammasome in cerebrovascular diseases pathology and possible therapeutic targets. ASN Neuro 13:17590914211018100. https:\/\/doi.org\/10.1177\/17590914211018100","journal-title":"ASN Neuro"},{"key":"5416_CR18","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/4293206","volume":"2020","author":"Y Tong","year":"2020","unstructured":"Tong Y, Wang Z, Cai L et al (2020) NLRP3 inflammasome and its central role in the cardiovascular diseases. Oxid Med Cell Longev 2020:4293206. https:\/\/doi.org\/10.1155\/2020\/4293206","journal-title":"Oxid Med Cell Longev"},{"key":"5416_CR19","doi-asserted-by":"publisher","first-page":"1090601","DOI":"10.3389\/fcvm.2022.1090601","volume":"9","author":"SH Wang","year":"2022","unstructured":"Wang SH, Sun MJ, Ding SY et al (2022) Ticagrelor reduces doxorubicin-induced pyroptosis of rat cardiomyocytes by targeting GSK-3\u03b2\/caspase-1. Frontiers Cardiovasc Med 9:1090601. https:\/\/doi.org\/10.3389\/fcvm.2022.1090601","journal-title":"Frontiers Cardiovasc Med"},{"key":"5416_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101523","volume":"34","author":"C Zeng","year":"2020","unstructured":"Zeng C, Duan F, Hu J et al (2020) Nlrp3 inflammasome-mediated pyroptosis contributes to the pathogenesis of non-ischemic dilated cardiomyopathy. Redox Biol 34:101523. https:\/\/doi.org\/10.1016\/j.redox.2020.101523","journal-title":"Redox Biol"},{"issue":"10","key":"5416_CR21","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/s41419-020-03120-6","volume":"11","author":"Z Li","year":"2020","unstructured":"Li Z, Xu H, Liu X et al (2020) GDF11 inhibits cardiomyocyte pyroptosis and exerts cardioprotection in acute myocardial infarction mice by upregulation of transcription factor HOXA3 [J]. Cell Death Dis 11(10):917. https:\/\/doi.org\/10.1038\/s41419-020-03120-6","journal-title":"Cell Death Dis"},{"key":"5416_CR22","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.92885","author":"C Wang","year":"2024","unstructured":"Wang C, Kaur K, Xu C et al (2024) Chemotherapy activates inflammasomes to cause inflammation-associated bone loss. Elife. https:\/\/doi.org\/10.7554\/eLife.92885","journal-title":"Elife"},{"issue":"3","key":"5416_CR23","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1161\/circulationaha.119.045566","volume":"142","author":"L He","year":"2020","unstructured":"He L, Nguyen NB, Ardehali R et al (2020) Heart regeneration by endogenous stem cells and cardiomyocyte proliferation: controversy, fallacy, and progress. Circulation 142(3):275\u2013291. https:\/\/doi.org\/10.1161\/circulationaha.119.045566","journal-title":"Circulation"},{"key":"5416_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.00434","volume":"8","author":"W Ma","year":"2020","unstructured":"Ma W, Wei S, Zhang B et al (2020) Molecular mechanisms of cardiomyocyte death in drug-induced cardiotoxicity. Front Cell Dev Biol 8:434. https:\/\/doi.org\/10.3389\/fcell.2020.00434","journal-title":"Front Cell Dev Biol"},{"key":"5416_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2014.00123","volume":"5","author":"RT Kendall","year":"2014","unstructured":"Kendall RT, Feghali-Bostwick CA (2014) Fibroblasts in fibrosis: novel roles and mediators. Front Pharmacol 5:123. https:\/\/doi.org\/10.3389\/fphar.2014.00123","journal-title":"Front Pharmacol"},{"key":"5416_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/cells12040659","author":"M Kciuk","year":"2023","unstructured":"Kciuk M, Gieleci\u0144ska A, Mujwar S et al (2023) Doxorubicin-an agent with multiple mechanisms of anticancer activity. Cells. https:\/\/doi.org\/10.3390\/cells12040659","journal-title":"Cells"},{"issue":"6","key":"5416_CR27","doi-asserted-by":"publisher","first-page":"G909","DOI":"10.1152\/ajpgi.00159.2018","volume":"315","author":"L Wang","year":"2018","unstructured":"Wang L, Wang Y, Wang Z et al (2018) Growth differentiation factor 11 ameliorates experimental colitis by inhibiting NLRP3 inflammasome activation. Am J Physiol Gastrointest Liver Physiol 315(6):G909\u2013G920. https:\/\/doi.org\/10.1152\/ajpgi.00159.2018","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"5416_CR28","doi-asserted-by":"publisher","first-page":"E157","DOI":"10.1152\/ajpendo.00193.2009","volume":"297","author":"H Gilson","year":"2009","unstructured":"Gilson H, Schakman O, Kalista S et al (2009) Follistatin induces muscle hypertrophy through satellite cell proliferation and inhibition of both myostatin and activin. Am J Physiol Endocrinol Metab 297(1):E157\u2013E164. https:\/\/doi.org\/10.1152\/ajpendo.00193.2009","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"4","key":"5416_CR29","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12631","volume":"52","author":"H Luo","year":"2019","unstructured":"Luo H, Guo Y, Liu Y et al (2019) Growth differentiation factor 11 inhibits adipogenic differentiation by activating TGF-beta\/Smad signalling pathway. Cell Prolif 52(4):e12631. https:\/\/doi.org\/10.1111\/cpr.12631","journal-title":"Cell Prolif"},{"issue":"1","key":"5416_CR30","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12967-022-03229-6","volume":"20","author":"L Li","year":"2022","unstructured":"Li L, Gao Y, Liu Z et al (2022) GDF11 alleviates neointimal hyperplasia in a rat model of artery injury by regulating endothelial NLRP3 inflammasome activation and rapid re-endothelialization. J Transl Med 20(1):28. https:\/\/doi.org\/10.1186\/s12967-022-03229-6","journal-title":"J Transl Med"},{"key":"5416_CR31","doi-asserted-by":"publisher","unstructured":"Xiong F, Liu R, Li Y, et al. (2022) [Honokiol reduces doxorubicin-induced cardiotoxicity in vitro by inhibiting pyroptosis via activating AMPK\/Nrf2 signaling]. Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 42(8): 1205\u201311 https:\/\/doi.org\/10.12122\/j.issn.1673-4254.2022.08.13","DOI":"10.12122\/j.issn.1673-4254.2022.08.13"},{"issue":"3","key":"5416_CR32","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.1096\/fj.201801375RR","volume":"33","author":"W Li","year":"2019","unstructured":"Li W, Wang W, Liu L et al (2019) GDF11 antagonizes TNF-\u03b1-induced inflammation and protects against the development of inflammatory arthritis in mice. FASEB J 33(3):3317\u20133329. https:\/\/doi.org\/10.1096\/fj.201801375RR","journal-title":"FASEB J"},{"issue":"1","key":"5416_CR33","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12964-023-01077-5","volume":"21","author":"S Shi","year":"2023","unstructured":"Shi S, Chen Y, Luo Z et al (2023) Role of oxidative stress and inflammation-related signaling pathways in doxorubicin-induced cardiomyopathy. Cell Commun Signal 21(1):61. https:\/\/doi.org\/10.1186\/s12964-023-01077-5","journal-title":"Cell Commun Signal"},{"issue":"2","key":"5416_CR34","doi-asserted-by":"publisher","first-page":"760","DOI":"10.7150\/ijbs.65258","volume":"18","author":"CY Kong","year":"2022","unstructured":"Kong CY, Guo Z, Song P et al (2022) Underlying the mechanisms of doxorubicin-induced acute cardiotoxicity: oxidative stress and cell death. Int J Biol Sci 18(2):760\u2013770. https:\/\/doi.org\/10.7150\/ijbs.65258","journal-title":"Int J Biol Sci"},{"issue":"10","key":"5416_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0292124","volume":"18","author":"M Mao","year":"2023","unstructured":"Mao M, Zheng W, Deng B et al (2023) Cinnamaldehyde alleviates doxorubicin-induced cardiotoxicity by decreasing oxidative stress and ferroptosis in cardiomyocytes. PLoS ONE 18(10):e0292124. https:\/\/doi.org\/10.1371\/journal.pone.0292124","journal-title":"PLoS ONE"},{"issue":"3","key":"5416_CR36","doi-asserted-by":"publisher","DOI":"10.31083\/j.fbl2803045","volume":"28","author":"X Chen","year":"2023","unstructured":"Chen X, Tian C, Zhang Z et al (2023) Astragaloside IV inhibits NLRP3 inflammasome-mediated pyroptosis via activation of Nrf-2\/HO-1 signaling pathway and protects against doxorubicin-induced cardiac dysfunction. Frontiers Bioscience-Landmark 28(3):45. https:\/\/doi.org\/10.31083\/j.fbl2803045","journal-title":"Frontiers Bioscience-Landmark"},{"issue":"1\u20132","key":"5416_CR37","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/s0005-2736(02)00612-0","volume":"1567","author":"S Hrelia","year":"2002","unstructured":"Hrelia S, Fiorentini D, Maraldi T et al (2002) Doxorubicin induces early lipid peroxidation associated with changes in glucose transport in cultured cardiomyocytes. Biochem Biophys Acta 1567(1\u20132):150\u2013156. https:\/\/doi.org\/10.1016\/s0005-2736(02)00612-0","journal-title":"Biochem Biophys Acta"},{"issue":"7","key":"5416_CR38","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1016\/S0735-1097(01)01665-5","volume":"38","author":"X Zhang","year":"2001","unstructured":"Zhang X, Azhar G, Nagano K et al (2001) Differential vulnerability to oxidative stress in rat cardiac myocytes versus fibroblasts. J Am Coll Cardiol 38(7):2055\u20132062","journal-title":"J Am Coll Cardiol"},{"key":"5416_CR39","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1196\/annals.1378.045","volume":"1090","author":"R Navarro","year":"2006","unstructured":"Navarro R, Busnadiego I, Ruiz-Larrea MB et al (2006) Superoxide anions are involved in doxorubicin-induced ERK activation in hepatocyte cultures. Ann N Y Acad Sci 1090:419\u2013428. https:\/\/doi.org\/10.1196\/annals.1378.045","journal-title":"Ann N Y Acad Sci"},{"key":"5416_CR40","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/4938287","volume":"2023","author":"Z Ping","year":"2023","unstructured":"Ping Z, Fangfang T, Yuliang Z et al (2023) Oxidative stress and pyroptosis in doxorubicin-induced heart failure and atrial fibrillation. Oxid Med Cell Longev 2023:4938287. https:\/\/doi.org\/10.1155\/2023\/4938287","journal-title":"Oxid Med Cell Longev"},{"issue":"11","key":"5416_CR41","doi-asserted-by":"publisher","DOI":"10.1590\/s0102-865020190110000006","volume":"34","author":"Z Bin","year":"2020","unstructured":"Bin Z, Yanli Y, Zhen Q et al (2020) GDF11 ameliorated myocardial ischemia reperfusion injury by antioxidant stress and up-regulating autophagy in STZ-induced type 1 diabetic rats. Acta Cir Bras 34(11):e201901106. https:\/\/doi.org\/10.1590\/s0102-865020190110000006","journal-title":"Acta Cir Bras"},{"issue":"10","key":"5416_CR42","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1002\/sctm.20-0005","volume":"9","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Zhu J, Zhang N et al (2020) GDF11 enhances therapeutic efficacy of mesenchymal stem cells for myocardial infarction via YME1L-mediated OPA1 processing [J]. Stem Cells Transl Med 9(10):1257\u20131271. https:\/\/doi.org\/10.1002\/sctm.20-0005","journal-title":"Stem Cells Transl Med"},{"key":"5416_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.104273","volume":"146","author":"V Garrido-Moreno","year":"2019","unstructured":"Garrido-Moreno V, D\u00edaz-Vegas A, L\u00f3pez-Crisosto C et al (2019) GDF-11 prevents cardiomyocyte hypertrophy by maintaining the sarcoplasmic reticulum-mitochondria communication. Pharmacol Res 146:104273. https:\/\/doi.org\/10.1016\/j.phrs.2019.104273","journal-title":"Pharmacol Res"},{"issue":"1","key":"5416_CR44","doi-asserted-by":"publisher","first-page":"3974","DOI":"10.1038\/s41598-021-83545-x","volume":"11","author":"A Xiao","year":"2021","unstructured":"Xiao A, Zhang Y, Ren Y et al (2021) GDF11 alleviates secondary brain injury after intracerebral hemorrhage via attenuating mitochondrial dynamic abnormality and dysfunction [J]. Sci Rep 11(1):3974. https:\/\/doi.org\/10.1038\/s41598-021-83545-x","journal-title":"Sci Rep"},{"issue":"1","key":"5416_CR45","doi-asserted-by":"publisher","first-page":"55","DOI":"10.22092\/ari.2019.116862.1177","volume":"75","author":"H Babaei","year":"2020","unstructured":"Babaei H, Razmaraii N, Assadnassab G et al (2020) Ultrastructural and echocardiographic assessment of chronic doxorubicin-induced cardiotoxicity in rats. Arch Razi Inst 75(1):55\u201362. https:\/\/doi.org\/10.22092\/ari.2019.116862.1177","journal-title":"Arch Razi Inst"}],"updated-by":[{"DOI":"10.1007\/s11010-025-05472-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000}}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-025-05416-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-025-05416-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-025-05416-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T09:26:01Z","timestamp":1771061161000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-025-05416-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["5416"],"URL":"https:\/\/doi.org\/10.1007\/s11010-025-05416-7","relation":{},"ISSN":["1573-4919"],"issn-type":[{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,24]]},"assertion":[{"value":"24 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original article has been revised due to incorrect Figure 3c","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s11010-025-05472-z","URL":"https:\/\/doi.org\/10.1007\/s11010-025-05472-z","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}